Global Passive Immunizing Drugs Against Rabies Market Research Report 2026(Status and Outlook)
Passive immunization against rabies refers to the administration of pre-formed antibodies,to provide immediate but temporary protection against the rabies virus.This approach delivers antibodies directly to neutralize the virus and prevent it from spreading,offering short-term immunity while the recipient's own immune system is stimulated by the rabies vaccine to develop a long-lasting immune response,which is especially critical in the early stages following potential exposure to rabies.
The global Passive Immunizing Drugs Against Rabies market size was estimated at USD 115.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Passive Immunizing Drugs Against Rabies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Passive Immunizing Drugs Against Rabies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Passive Immunizing Drugs Against Rabies market.
Global Passive Immunizing Drugs Against Rabies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Kedrion Biopharma
Grifols
Sanofi Pasteur
Kamada
Zydus Lifesciences
Serum Institute of India
Sichuan Yuanda Shuyang Pharmaceutical
Sinopharm Group
Haffkine Bio-Pharmaceutical
Bharat Biotech
Sharon Bio-Medicine
Wuhan Institute of Biological Products
North China Pharmaceutical
Xingmeng Biopharmaceuticals (Suzhou)
Hualan Biological Engineering
Shanxi Kangbao Biological Product
Market Segmentation (by Type)
Rabies Immunoglobulin
Anti-rabies Serum
Rabies Virus Monoclonal Antibody
Market Segmentation (by Application)
Category II Exposure
Category III Exposure
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Passive Immunizing Drugs Against Rabies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Passive Immunizing Drugs Against Rabies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Passive Immunizing Drugs Against Rabies market size was estimated at USD 115.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Passive Immunizing Drugs Against Rabies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Passive Immunizing Drugs Against Rabies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Passive Immunizing Drugs Against Rabies market.
Global Passive Immunizing Drugs Against Rabies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Kedrion Biopharma
Grifols
Sanofi Pasteur
Kamada
Zydus Lifesciences
Serum Institute of India
Sichuan Yuanda Shuyang Pharmaceutical
Sinopharm Group
Haffkine Bio-Pharmaceutical
Bharat Biotech
Sharon Bio-Medicine
Wuhan Institute of Biological Products
North China Pharmaceutical
Xingmeng Biopharmaceuticals (Suzhou)
Hualan Biological Engineering
Shanxi Kangbao Biological Product
Market Segmentation (by Type)
Rabies Immunoglobulin
Anti-rabies Serum
Rabies Virus Monoclonal Antibody
Market Segmentation (by Application)
Category II Exposure
Category III Exposure
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Passive Immunizing Drugs Against Rabies Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Passive Immunizing Drugs Against Rabies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Passive Immunizing Drugs Against Rabies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Passive Immunizing Drugs Against Rabies
1.2 Key Market Segments
1.2.1 Passive Immunizing Drugs Against Rabies Segment by Type
1.2.2 Passive Immunizing Drugs Against Rabies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Passive Immunizing Drugs Against Rabies Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Passive Immunizing Drugs Against Rabies Product Life Cycle
3.3 Global Passive Immunizing Drugs Against Rabies Sales by Manufacturers (2020-2025)
3.4 Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Manufacturers (2020-2025)
3.5 Passive Immunizing Drugs Against Rabies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Passive Immunizing Drugs Against Rabies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Passive Immunizing Drugs Against Rabies Market Competitive Situation and Trends
3.8.1 Passive Immunizing Drugs Against Rabies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Passive Immunizing Drugs Against Rabies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PASSIVE IMMUNIZING DRUGS AGAINST RABIES INDUSTRY CHAIN ANALYSIS
4.1 Passive Immunizing Drugs Against Rabies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Passive Immunizing Drugs Against Rabies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Passive Immunizing Drugs Against Rabies Market
5.7 ESG Ratings of Leading Companies
6 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Passive Immunizing Drugs Against Rabies Sales Market Share by Type (2020-2025)
6.3 Global Passive Immunizing Drugs Against Rabies Market Size by Type (2020-2025)
6.4 Global Passive Immunizing Drugs Against Rabies Price by Type (2020-2025)
7 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Passive Immunizing Drugs Against Rabies Market Sales by Application (2020-2025)
7.3 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) by Application (2020-2025)
7.4 Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
8 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SALES BY REGION
8.1 Global Passive Immunizing Drugs Against Rabies Sales by Region
8.1.1 Global Passive Immunizing Drugs Against Rabies Sales by Region
8.1.2 Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region
8.2 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.2.1 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.2.2 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.3 North America
8.3.1 North America Passive Immunizing Drugs Against Rabies Sales by Country
8.3.2 North America Passive Immunizing Drugs Against Rabies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Passive Immunizing Drugs Against Rabies Sales by Country
8.4.2 Europe Passive Immunizing Drugs Against Rabies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Passive Immunizing Drugs Against Rabies Sales by Region
8.5.2 Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Passive Immunizing Drugs Against Rabies Sales by Country
8.6.2 South America Passive Immunizing Drugs Against Rabies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Passive Immunizing Drugs Against Rabies Sales by Region
8.7.2 Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET PRODUCTION BY REGION
9.1 Global Production of Passive Immunizing Drugs Against Rabies by Region(2020-2025)
9.2 Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Region (2020-2025)
9.3 Global Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Passive Immunizing Drugs Against Rabies Production
9.4.1 North America Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.4.2 North America Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Passive Immunizing Drugs Against Rabies Production
9.5.1 Europe Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.5.2 Europe Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Passive Immunizing Drugs Against Rabies Production (2020-2025)
9.6.1 Japan Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.6.2 Japan Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Passive Immunizing Drugs Against Rabies Production (2020-2025)
9.7.1 China Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.7.2 China Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Kedrion Biopharma
10.1.1 Kedrion Biopharma Basic Information
10.1.2 Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Overview
10.1.3 Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Market Performance
10.1.4 Kedrion Biopharma Business Overview
10.1.5 Kedrion Biopharma SWOT Analysis
10.1.6 Kedrion Biopharma Recent Developments
10.2 Grifols
10.2.1 Grifols Basic Information
10.2.2 Grifols Passive Immunizing Drugs Against Rabies Product Overview
10.2.3 Grifols Passive Immunizing Drugs Against Rabies Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Overview
10.3.3 Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Kamada
10.4.1 Kamada Basic Information
10.4.2 Kamada Passive Immunizing Drugs Against Rabies Product Overview
10.4.3 Kamada Passive Immunizing Drugs Against Rabies Product Market Performance
10.4.4 Kamada Business Overview
10.4.5 Kamada Recent Developments
10.5 Zydus Lifesciences
10.5.1 Zydus Lifesciences Basic Information
10.5.2 Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Overview
10.5.3 Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Market Performance
10.5.4 Zydus Lifesciences Business Overview
10.5.5 Zydus Lifesciences Recent Developments
10.6 Serum Institute of India
10.6.1 Serum Institute of India Basic Information
10.6.2 Serum Institute of India Passive Immunizing Drugs Against Rabies Product Overview
10.6.3 Serum Institute of India Passive Immunizing Drugs Against Rabies Product Market Performance
10.6.4 Serum Institute of India Business Overview
10.6.5 Serum Institute of India Recent Developments
10.7 Sichuan Yuanda Shuyang Pharmaceutical
10.7.1 Sichuan Yuanda Shuyang Pharmaceutical Basic Information
10.7.2 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.7.4 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
10.7.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
10.8 Sinopharm Group
10.8.1 Sinopharm Group Basic Information
10.8.2 Sinopharm Group Passive Immunizing Drugs Against Rabies Product Overview
10.8.3 Sinopharm Group Passive Immunizing Drugs Against Rabies Product Market Performance
10.8.4 Sinopharm Group Business Overview
10.8.5 Sinopharm Group Recent Developments
10.9 Haffkine Bio-Pharmaceutical
10.9.1 Haffkine Bio-Pharmaceutical Basic Information
10.9.2 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.9.4 Haffkine Bio-Pharmaceutical Business Overview
10.9.5 Haffkine Bio-Pharmaceutical Recent Developments
10.10 Bharat Biotech
10.10.1 Bharat Biotech Basic Information
10.10.2 Bharat Biotech Passive Immunizing Drugs Against Rabies Product Overview
10.10.3 Bharat Biotech Passive Immunizing Drugs Against Rabies Product Market Performance
10.10.4 Bharat Biotech Business Overview
10.10.5 Bharat Biotech Recent Developments
10.11 Sharon Bio-Medicine
10.11.1 Sharon Bio-Medicine Basic Information
10.11.2 Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Overview
10.11.3 Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Market Performance
10.11.4 Sharon Bio-Medicine Business Overview
10.11.5 Sharon Bio-Medicine Recent Developments
10.12 Wuhan Institute of Biological Products
10.12.1 Wuhan Institute of Biological Products Basic Information
10.12.2 Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Overview
10.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Market Performance
10.12.4 Wuhan Institute of Biological Products Business Overview
10.12.5 Wuhan Institute of Biological Products Recent Developments
10.13 North China Pharmaceutical
10.13.1 North China Pharmaceutical Basic Information
10.13.2 North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.13.3 North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.13.4 North China Pharmaceutical Business Overview
10.13.5 North China Pharmaceutical Recent Developments
10.14 Xingmeng Biopharmaceuticals (Suzhou)
10.14.1 Xingmeng Biopharmaceuticals (Suzhou) Basic Information
10.14.2 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Overview
10.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Market Performance
10.14.4 Xingmeng Biopharmaceuticals (Suzhou) Business Overview
10.14.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
10.15 Hualan Biological Engineering
10.15.1 Hualan Biological Engineering Basic Information
10.15.2 Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Overview
10.15.3 Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Market Performance
10.15.4 Hualan Biological Engineering Business Overview
10.15.5 Hualan Biological Engineering Recent Developments
10.16 Shanxi Kangbao Biological Product
10.16.1 Shanxi Kangbao Biological Product Basic Information
10.16.2 Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Overview
10.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Market Performance
10.16.4 Shanxi Kangbao Biological Product Business Overview
10.16.5 Shanxi Kangbao Biological Product Recent Developments
11 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET FORECAST BY REGION
11.1 Global Passive Immunizing Drugs Against Rabies Market Size Forecast
11.2 Global Passive Immunizing Drugs Against Rabies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Passive Immunizing Drugs Against Rabies Market Size Forecast by Country
11.2.3 Asia Pacific Passive Immunizing Drugs Against Rabies Market Size Forecast by Region
11.2.4 South America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Passive Immunizing Drugs Against Rabies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Passive Immunizing Drugs Against Rabies Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Passive Immunizing Drugs Against Rabies by Type (2026-2035)
12.1.2 Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Passive Immunizing Drugs Against Rabies by Type (2026-2035)
12.2 Global Passive Immunizing Drugs Against Rabies Market Forecast by Application (2026-2035)
12.2.1 Global Passive Immunizing Drugs Against Rabies Sales (K MT) Forecast by Application
12.2.2 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Passive Immunizing Drugs Against Rabies
1.2 Key Market Segments
1.2.1 Passive Immunizing Drugs Against Rabies Segment by Type
1.2.2 Passive Immunizing Drugs Against Rabies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Passive Immunizing Drugs Against Rabies Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Passive Immunizing Drugs Against Rabies Product Life Cycle
3.3 Global Passive Immunizing Drugs Against Rabies Sales by Manufacturers (2020-2025)
3.4 Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Manufacturers (2020-2025)
3.5 Passive Immunizing Drugs Against Rabies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Passive Immunizing Drugs Against Rabies Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Passive Immunizing Drugs Against Rabies Market Competitive Situation and Trends
3.8.1 Passive Immunizing Drugs Against Rabies Market Concentration Rate
3.8.2 Global 5 and 10 Largest Passive Immunizing Drugs Against Rabies Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PASSIVE IMMUNIZING DRUGS AGAINST RABIES INDUSTRY CHAIN ANALYSIS
4.1 Passive Immunizing Drugs Against Rabies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Passive Immunizing Drugs Against Rabies Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Passive Immunizing Drugs Against Rabies Market
5.7 ESG Ratings of Leading Companies
6 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Passive Immunizing Drugs Against Rabies Sales Market Share by Type (2020-2025)
6.3 Global Passive Immunizing Drugs Against Rabies Market Size by Type (2020-2025)
6.4 Global Passive Immunizing Drugs Against Rabies Price by Type (2020-2025)
7 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Passive Immunizing Drugs Against Rabies Market Sales by Application (2020-2025)
7.3 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) by Application (2020-2025)
7.4 Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
8 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET SALES BY REGION
8.1 Global Passive Immunizing Drugs Against Rabies Sales by Region
8.1.1 Global Passive Immunizing Drugs Against Rabies Sales by Region
8.1.2 Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region
8.2 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.2.1 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.2.2 Global Passive Immunizing Drugs Against Rabies Market Size by Region
8.3 North America
8.3.1 North America Passive Immunizing Drugs Against Rabies Sales by Country
8.3.2 North America Passive Immunizing Drugs Against Rabies Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Passive Immunizing Drugs Against Rabies Sales by Country
8.4.2 Europe Passive Immunizing Drugs Against Rabies Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Passive Immunizing Drugs Against Rabies Sales by Region
8.5.2 Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Passive Immunizing Drugs Against Rabies Sales by Country
8.6.2 South America Passive Immunizing Drugs Against Rabies Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Passive Immunizing Drugs Against Rabies Sales by Region
8.7.2 Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET PRODUCTION BY REGION
9.1 Global Production of Passive Immunizing Drugs Against Rabies by Region(2020-2025)
9.2 Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Region (2020-2025)
9.3 Global Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Passive Immunizing Drugs Against Rabies Production
9.4.1 North America Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.4.2 North America Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Passive Immunizing Drugs Against Rabies Production
9.5.1 Europe Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.5.2 Europe Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Passive Immunizing Drugs Against Rabies Production (2020-2025)
9.6.1 Japan Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.6.2 Japan Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Passive Immunizing Drugs Against Rabies Production (2020-2025)
9.7.1 China Passive Immunizing Drugs Against Rabies Production Growth Rate (2020-2025)
9.7.2 China Passive Immunizing Drugs Against Rabies Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Kedrion Biopharma
10.1.1 Kedrion Biopharma Basic Information
10.1.2 Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Overview
10.1.3 Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Market Performance
10.1.4 Kedrion Biopharma Business Overview
10.1.5 Kedrion Biopharma SWOT Analysis
10.1.6 Kedrion Biopharma Recent Developments
10.2 Grifols
10.2.1 Grifols Basic Information
10.2.2 Grifols Passive Immunizing Drugs Against Rabies Product Overview
10.2.3 Grifols Passive Immunizing Drugs Against Rabies Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols SWOT Analysis
10.2.6 Grifols Recent Developments
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Basic Information
10.3.2 Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Overview
10.3.3 Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Market Performance
10.3.4 Sanofi Pasteur Business Overview
10.3.5 Sanofi Pasteur SWOT Analysis
10.3.6 Sanofi Pasteur Recent Developments
10.4 Kamada
10.4.1 Kamada Basic Information
10.4.2 Kamada Passive Immunizing Drugs Against Rabies Product Overview
10.4.3 Kamada Passive Immunizing Drugs Against Rabies Product Market Performance
10.4.4 Kamada Business Overview
10.4.5 Kamada Recent Developments
10.5 Zydus Lifesciences
10.5.1 Zydus Lifesciences Basic Information
10.5.2 Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Overview
10.5.3 Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Market Performance
10.5.4 Zydus Lifesciences Business Overview
10.5.5 Zydus Lifesciences Recent Developments
10.6 Serum Institute of India
10.6.1 Serum Institute of India Basic Information
10.6.2 Serum Institute of India Passive Immunizing Drugs Against Rabies Product Overview
10.6.3 Serum Institute of India Passive Immunizing Drugs Against Rabies Product Market Performance
10.6.4 Serum Institute of India Business Overview
10.6.5 Serum Institute of India Recent Developments
10.7 Sichuan Yuanda Shuyang Pharmaceutical
10.7.1 Sichuan Yuanda Shuyang Pharmaceutical Basic Information
10.7.2 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.7.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.7.4 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
10.7.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
10.8 Sinopharm Group
10.8.1 Sinopharm Group Basic Information
10.8.2 Sinopharm Group Passive Immunizing Drugs Against Rabies Product Overview
10.8.3 Sinopharm Group Passive Immunizing Drugs Against Rabies Product Market Performance
10.8.4 Sinopharm Group Business Overview
10.8.5 Sinopharm Group Recent Developments
10.9 Haffkine Bio-Pharmaceutical
10.9.1 Haffkine Bio-Pharmaceutical Basic Information
10.9.2 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.9.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.9.4 Haffkine Bio-Pharmaceutical Business Overview
10.9.5 Haffkine Bio-Pharmaceutical Recent Developments
10.10 Bharat Biotech
10.10.1 Bharat Biotech Basic Information
10.10.2 Bharat Biotech Passive Immunizing Drugs Against Rabies Product Overview
10.10.3 Bharat Biotech Passive Immunizing Drugs Against Rabies Product Market Performance
10.10.4 Bharat Biotech Business Overview
10.10.5 Bharat Biotech Recent Developments
10.11 Sharon Bio-Medicine
10.11.1 Sharon Bio-Medicine Basic Information
10.11.2 Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Overview
10.11.3 Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Market Performance
10.11.4 Sharon Bio-Medicine Business Overview
10.11.5 Sharon Bio-Medicine Recent Developments
10.12 Wuhan Institute of Biological Products
10.12.1 Wuhan Institute of Biological Products Basic Information
10.12.2 Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Overview
10.12.3 Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Market Performance
10.12.4 Wuhan Institute of Biological Products Business Overview
10.12.5 Wuhan Institute of Biological Products Recent Developments
10.13 North China Pharmaceutical
10.13.1 North China Pharmaceutical Basic Information
10.13.2 North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
10.13.3 North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Market Performance
10.13.4 North China Pharmaceutical Business Overview
10.13.5 North China Pharmaceutical Recent Developments
10.14 Xingmeng Biopharmaceuticals (Suzhou)
10.14.1 Xingmeng Biopharmaceuticals (Suzhou) Basic Information
10.14.2 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Overview
10.14.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Market Performance
10.14.4 Xingmeng Biopharmaceuticals (Suzhou) Business Overview
10.14.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
10.15 Hualan Biological Engineering
10.15.1 Hualan Biological Engineering Basic Information
10.15.2 Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Overview
10.15.3 Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Market Performance
10.15.4 Hualan Biological Engineering Business Overview
10.15.5 Hualan Biological Engineering Recent Developments
10.16 Shanxi Kangbao Biological Product
10.16.1 Shanxi Kangbao Biological Product Basic Information
10.16.2 Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Overview
10.16.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Market Performance
10.16.4 Shanxi Kangbao Biological Product Business Overview
10.16.5 Shanxi Kangbao Biological Product Recent Developments
11 PASSIVE IMMUNIZING DRUGS AGAINST RABIES MARKET FORECAST BY REGION
11.1 Global Passive Immunizing Drugs Against Rabies Market Size Forecast
11.2 Global Passive Immunizing Drugs Against Rabies Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Passive Immunizing Drugs Against Rabies Market Size Forecast by Country
11.2.3 Asia Pacific Passive Immunizing Drugs Against Rabies Market Size Forecast by Region
11.2.4 South America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Passive Immunizing Drugs Against Rabies by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Passive Immunizing Drugs Against Rabies Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Passive Immunizing Drugs Against Rabies by Type (2026-2035)
12.1.2 Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Passive Immunizing Drugs Against Rabies by Type (2026-2035)
12.2 Global Passive Immunizing Drugs Against Rabies Market Forecast by Application (2026-2035)
12.2.1 Global Passive Immunizing Drugs Against Rabies Sales (K MT) Forecast by Application
12.2.2 Global Passive Immunizing Drugs Against Rabies Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Passive Immunizing Drugs Against Rabies Market Size by Type (M USD)
Table 4. Global Passive Immunizing Drugs Against Rabies Market Size by Application
Table 5. Passive Immunizing Drugs Against Rabies Market Size Comparison by Region (M USD)
Table 6. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Passive Immunizing Drugs Against Rabies Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Passive Immunizing Drugs Against Rabies Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Immunizing Drugs Against Rabies as of 2025)
Table 11. Global Market Passive Immunizing Drugs Against Rabies Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Passive Immunizing Drugs Against Rabies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Passive Immunizing Drugs Against Rabies Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Passive Immunizing Drugs Against Rabies Sales by Type (K MT)
Table 27. Global Passive Immunizing Drugs Against Rabies Market Size by Type (M USD)
Table 28. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Type (2020-2025)
Table 29. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Type (2020-2025)
Table 30. Global Passive Immunizing Drugs Against Rabies Market Size (M USD) by Type (2020-2025)
Table 31. Global Passive Immunizing Drugs Against Rabies Market Share by Type (2020-2025)
Table 32. Global Passive Immunizing Drugs Against Rabies Price (USD/KG) by Type (2020-2025)
Table 33. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Application
Table 34. Global Passive Immunizing Drugs Against Rabies Market Size by Application
Table 35. Global Passive Immunizing Drugs Against Rabies Sales by Application (2020-2025) & (K MT)
Table 36. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application (2020-2025)
Table 37. Global Passive Immunizing Drugs Against Rabies Market Size by Application (2020-2025) & (M USD)
Table 38. Global Passive Immunizing Drugs Against Rabies Market Share by Application (2020-2025)
Table 39. Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
Table 40. Global Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 41. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region (2020-2025)
Table 42. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 43. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025)
Table 44. North America Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 45. North America Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 47. Europe Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 50. South America Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 51. South America Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 54. Global Passive Immunizing Drugs Against Rabies Production (K MT) by Region(2020-2025)
Table 55. Global Passive Immunizing Drugs Against Rabies Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Region (2020-2025)
Table 57. Global Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Kedrion Biopharma Basic Information
Table 63. Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Overview
Table 64. Kedrion Biopharma Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Kedrion Biopharma Business Overview
Table 66. Kedrion Biopharma SWOT Analysis
Table 67. Kedrion Biopharma Recent Developments
Table 68. Grifols Basic Information
Table 69. Grifols Passive Immunizing Drugs Against Rabies Product Overview
Table 70. Grifols Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Grifols Business Overview
Table 72. Grifols SWOT Analysis
Table 73. Grifols Recent Developments
Table 74. Sanofi Pasteur Basic Information
Table 75. Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Overview
Table 76. Sanofi Pasteur Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Pasteur Business Overview
Table 78. Sanofi Pasteur SWOT Analysis
Table 79. Sanofi Pasteur Recent Developments
Table 80. Kamada Basic Information
Table 81. Kamada Passive Immunizing Drugs Against Rabies Product Overview
Table 82. Kamada Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Kamada Business Overview
Table 84. Kamada Recent Developments
Table 85. Zydus Lifesciences Basic Information
Table 86. Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Overview
Table 87. Zydus Lifesciences Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Zydus Lifesciences Business Overview
Table 89. Zydus Lifesciences Recent Developments
Table 90. Serum Institute of India Basic Information
Table 91. Serum Institute of India Passive Immunizing Drugs Against Rabies Product Overview
Table 92. Serum Institute of India Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Serum Institute of India Business Overview
Table 94. Serum Institute of India Recent Developments
Table 95. Sichuan Yuanda Shuyang Pharmaceutical Basic Information
Table 96. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 97. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 99. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
Table 100. Sinopharm Group Basic Information
Table 101. Sinopharm Group Passive Immunizing Drugs Against Rabies Product Overview
Table 102. Sinopharm Group Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinopharm Group Business Overview
Table 104. Sinopharm Group Recent Developments
Table 105. Haffkine Bio-Pharmaceutical Basic Information
Table 106. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 107. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Haffkine Bio-Pharmaceutical Business Overview
Table 109. Haffkine Bio-Pharmaceutical Recent Developments
Table 110. Bharat Biotech Basic Information
Table 111. Bharat Biotech Passive Immunizing Drugs Against Rabies Product Overview
Table 112. Bharat Biotech Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bharat Biotech Business Overview
Table 114. Bharat Biotech Recent Developments
Table 115. Sharon Bio-Medicine Basic Information
Table 116. Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Overview
Table 117. Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sharon Bio-Medicine Business Overview
Table 119. Sharon Bio-Medicine Recent Developments
Table 120. Wuhan Institute of Biological Products Basic Information
Table 121. Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Overview
Table 122. Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Wuhan Institute of Biological Products Business Overview
Table 124. Wuhan Institute of Biological Products Recent Developments
Table 125. North China Pharmaceutical Basic Information
Table 126. North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 127. North China Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. North China Pharmaceutical Business Overview
Table 129. North China Pharmaceutical Recent Developments
Table 130. Xingmeng Biopharmaceuticals (Suzhou) Basic Information
Table 131. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Overview
Table 132. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Xingmeng Biopharmaceuticals (Suzhou) Business Overview
Table 134. Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
Table 135. Hualan Biological Engineering Basic Information
Table 136. Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Overview
Table 137. Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Hualan Biological Engineering Business Overview
Table 139. Hualan Biological Engineering Recent Developments
Table 140. Shanxi Kangbao Biological Product Basic Information
Table 141. Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Overview
Table 142. Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Shanxi Kangbao Biological Product Business Overview
Table 144. Shanxi Kangbao Biological Product Recent Developments
Table 145. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Passive Immunizing Drugs Against Rabies Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Passive Immunizing Drugs Against Rabies Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Passive Immunizing Drugs Against Rabies Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Passive Immunizing Drugs Against Rabies Market Size by Type (M USD)
Table 4. Global Passive Immunizing Drugs Against Rabies Market Size by Application
Table 5. Passive Immunizing Drugs Against Rabies Market Size Comparison by Region (M USD)
Table 6. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Passive Immunizing Drugs Against Rabies Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Passive Immunizing Drugs Against Rabies Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Immunizing Drugs Against Rabies as of 2025)
Table 11. Global Market Passive Immunizing Drugs Against Rabies Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Passive Immunizing Drugs Against Rabies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Passive Immunizing Drugs Against Rabies Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Passive Immunizing Drugs Against Rabies Sales by Type (K MT)
Table 27. Global Passive Immunizing Drugs Against Rabies Market Size by Type (M USD)
Table 28. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Type (2020-2025)
Table 29. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Type (2020-2025)
Table 30. Global Passive Immunizing Drugs Against Rabies Market Size (M USD) by Type (2020-2025)
Table 31. Global Passive Immunizing Drugs Against Rabies Market Share by Type (2020-2025)
Table 32. Global Passive Immunizing Drugs Against Rabies Price (USD/KG) by Type (2020-2025)
Table 33. Global Passive Immunizing Drugs Against Rabies Sales (K MT) by Application
Table 34. Global Passive Immunizing Drugs Against Rabies Market Size by Application
Table 35. Global Passive Immunizing Drugs Against Rabies Sales by Application (2020-2025) & (K MT)
Table 36. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application (2020-2025)
Table 37. Global Passive Immunizing Drugs Against Rabies Market Size by Application (2020-2025) & (M USD)
Table 38. Global Passive Immunizing Drugs Against Rabies Market Share by Application (2020-2025)
Table 39. Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
Table 40. Global Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 41. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region (2020-2025)
Table 42. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 43. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025)
Table 44. North America Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 45. North America Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 47. Europe Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 50. South America Passive Immunizing Drugs Against Rabies Sales by Country (2020-2025) & (K MT)
Table 51. South America Passive Immunizing Drugs Against Rabies Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025) & (M USD)
Table 54. Global Passive Immunizing Drugs Against Rabies Production (K MT) by Region(2020-2025)
Table 55. Global Passive Immunizing Drugs Against Rabies Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Passive Immunizing Drugs Against Rabies Revenue Market Share by Region (2020-2025)
Table 57. Global Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Passive Immunizing Drugs Against Rabies Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Kedrion Biopharma Basic Information
Table 63. Kedrion Biopharma Passive Immunizing Drugs Against Rabies Product Overview
Table 64. Kedrion Biopharma Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Kedrion Biopharma Business Overview
Table 66. Kedrion Biopharma SWOT Analysis
Table 67. Kedrion Biopharma Recent Developments
Table 68. Grifols Basic Information
Table 69. Grifols Passive Immunizing Drugs Against Rabies Product Overview
Table 70. Grifols Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Grifols Business Overview
Table 72. Grifols SWOT Analysis
Table 73. Grifols Recent Developments
Table 74. Sanofi Pasteur Basic Information
Table 75. Sanofi Pasteur Passive Immunizing Drugs Against Rabies Product Overview
Table 76. Sanofi Pasteur Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Pasteur Business Overview
Table 78. Sanofi Pasteur SWOT Analysis
Table 79. Sanofi Pasteur Recent Developments
Table 80. Kamada Basic Information
Table 81. Kamada Passive Immunizing Drugs Against Rabies Product Overview
Table 82. Kamada Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Kamada Business Overview
Table 84. Kamada Recent Developments
Table 85. Zydus Lifesciences Basic Information
Table 86. Zydus Lifesciences Passive Immunizing Drugs Against Rabies Product Overview
Table 87. Zydus Lifesciences Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Zydus Lifesciences Business Overview
Table 89. Zydus Lifesciences Recent Developments
Table 90. Serum Institute of India Basic Information
Table 91. Serum Institute of India Passive Immunizing Drugs Against Rabies Product Overview
Table 92. Serum Institute of India Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Serum Institute of India Business Overview
Table 94. Serum Institute of India Recent Developments
Table 95. Sichuan Yuanda Shuyang Pharmaceutical Basic Information
Table 96. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 97. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sichuan Yuanda Shuyang Pharmaceutical Business Overview
Table 99. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
Table 100. Sinopharm Group Basic Information
Table 101. Sinopharm Group Passive Immunizing Drugs Against Rabies Product Overview
Table 102. Sinopharm Group Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sinopharm Group Business Overview
Table 104. Sinopharm Group Recent Developments
Table 105. Haffkine Bio-Pharmaceutical Basic Information
Table 106. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 107. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Haffkine Bio-Pharmaceutical Business Overview
Table 109. Haffkine Bio-Pharmaceutical Recent Developments
Table 110. Bharat Biotech Basic Information
Table 111. Bharat Biotech Passive Immunizing Drugs Against Rabies Product Overview
Table 112. Bharat Biotech Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bharat Biotech Business Overview
Table 114. Bharat Biotech Recent Developments
Table 115. Sharon Bio-Medicine Basic Information
Table 116. Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Product Overview
Table 117. Sharon Bio-Medicine Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sharon Bio-Medicine Business Overview
Table 119. Sharon Bio-Medicine Recent Developments
Table 120. Wuhan Institute of Biological Products Basic Information
Table 121. Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Product Overview
Table 122. Wuhan Institute of Biological Products Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Wuhan Institute of Biological Products Business Overview
Table 124. Wuhan Institute of Biological Products Recent Developments
Table 125. North China Pharmaceutical Basic Information
Table 126. North China Pharmaceutical Passive Immunizing Drugs Against Rabies Product Overview
Table 127. North China Pharmaceutical Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. North China Pharmaceutical Business Overview
Table 129. North China Pharmaceutical Recent Developments
Table 130. Xingmeng Biopharmaceuticals (Suzhou) Basic Information
Table 131. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Product Overview
Table 132. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Xingmeng Biopharmaceuticals (Suzhou) Business Overview
Table 134. Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
Table 135. Hualan Biological Engineering Basic Information
Table 136. Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Product Overview
Table 137. Hualan Biological Engineering Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Hualan Biological Engineering Business Overview
Table 139. Hualan Biological Engineering Recent Developments
Table 140. Shanxi Kangbao Biological Product Basic Information
Table 141. Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Product Overview
Table 142. Shanxi Kangbao Biological Product Passive Immunizing Drugs Against Rabies Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Shanxi Kangbao Biological Product Business Overview
Table 144. Shanxi Kangbao Biological Product Recent Developments
Table 145. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Passive Immunizing Drugs Against Rabies Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Passive Immunizing Drugs Against Rabies Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Passive Immunizing Drugs Against Rabies Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Passive Immunizing Drugs Against Rabies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Passive Immunizing Drugs Against Rabies Market Size (M USD), 2025-2035
Figure 5. Global Passive Immunizing Drugs Against Rabies Market Size (M USD) (2020-2035)
Figure 6. Global Passive Immunizing Drugs Against Rabies Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Passive Immunizing Drugs Against Rabies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Passive Immunizing Drugs Against Rabies Product Life Cycle
Figure 13. Passive Immunizing Drugs Against Rabies Sales Share by Manufacturers in 2025
Figure 14. Global Passive Immunizing Drugs Against Rabies Revenue Share by Manufacturers in 2025
Figure 15. Passive Immunizing Drugs Against Rabies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Passive Immunizing Drugs Against Rabies Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Passive Immunizing Drugs Against Rabies Revenue in 2025
Figure 18. Industry Chain Map of Passive Immunizing Drugs Against Rabies
Figure 19. Global Passive Immunizing Drugs Against Rabies Market PEST Analysis
Figure 20. Global Passive Immunizing Drugs Against Rabies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Passive Immunizing Drugs Against Rabies Market Share by Type
Figure 27. Sales Market Share of Passive Immunizing Drugs Against Rabies by Type (2020-2025)
Figure 28. Sales Market Share of Passive Immunizing Drugs Against Rabies by Type in 2025
Figure 29. Market Share of Passive Immunizing Drugs Against Rabies by Type (2020-2025)
Figure 30. Market Share of Passive Immunizing Drugs Against Rabies by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Passive Immunizing Drugs Against Rabies Market Share by Application
Figure 33. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application (2020-2025)
Figure 34. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application in 2025
Figure 35. Global Passive Immunizing Drugs Against Rabies Market Share by Application (2020-2025)
Figure 36. Global Passive Immunizing Drugs Against Rabies Market Share by Application in 2025
Figure 37. Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region (2020-2025)
Figure 39. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025)
Figure 40. North America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 43. North America Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 45. U.S. Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Passive Immunizing Drugs Against Rabies Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Passive Immunizing Drugs Against Rabies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Passive Immunizing Drugs Against Rabies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Passive Immunizing Drugs Against Rabies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 53. Europe Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 55. Germany Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Passive Immunizing Drugs Against Rabies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region in 2024
Figure 68. China Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 79. South America Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 80. South America Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (M USD)
Figure 81. South America Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 82. Brazil Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region in 2024
Figure 92. Saudi Arabia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Passive Immunizing Drugs Against Rabies Production Market Share by Region (2020-2025)
Figure 103. North America Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 106. China Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Passive Immunizing Drugs Against Rabies Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Passive Immunizing Drugs Against Rabies Market Share Forecast by Type (2026-2035)
Figure 111. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Application (2026-2035)
Figure 112. Global Passive Immunizing Drugs Against Rabies Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Passive Immunizing Drugs Against Rabies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Passive Immunizing Drugs Against Rabies Market Size (M USD), 2025-2035
Figure 5. Global Passive Immunizing Drugs Against Rabies Market Size (M USD) (2020-2035)
Figure 6. Global Passive Immunizing Drugs Against Rabies Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Passive Immunizing Drugs Against Rabies Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Passive Immunizing Drugs Against Rabies Product Life Cycle
Figure 13. Passive Immunizing Drugs Against Rabies Sales Share by Manufacturers in 2025
Figure 14. Global Passive Immunizing Drugs Against Rabies Revenue Share by Manufacturers in 2025
Figure 15. Passive Immunizing Drugs Against Rabies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Passive Immunizing Drugs Against Rabies Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Passive Immunizing Drugs Against Rabies Revenue in 2025
Figure 18. Industry Chain Map of Passive Immunizing Drugs Against Rabies
Figure 19. Global Passive Immunizing Drugs Against Rabies Market PEST Analysis
Figure 20. Global Passive Immunizing Drugs Against Rabies Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Passive Immunizing Drugs Against Rabies Market Share by Type
Figure 27. Sales Market Share of Passive Immunizing Drugs Against Rabies by Type (2020-2025)
Figure 28. Sales Market Share of Passive Immunizing Drugs Against Rabies by Type in 2025
Figure 29. Market Share of Passive Immunizing Drugs Against Rabies by Type (2020-2025)
Figure 30. Market Share of Passive Immunizing Drugs Against Rabies by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Passive Immunizing Drugs Against Rabies Market Share by Application
Figure 33. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application (2020-2025)
Figure 34. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Application in 2025
Figure 35. Global Passive Immunizing Drugs Against Rabies Market Share by Application (2020-2025)
Figure 36. Global Passive Immunizing Drugs Against Rabies Market Share by Application in 2025
Figure 37. Global Passive Immunizing Drugs Against Rabies Sales Growth Rate by Application (2020-2025)
Figure 38. Global Passive Immunizing Drugs Against Rabies Sales Market Share by Region (2020-2025)
Figure 39. Global Passive Immunizing Drugs Against Rabies Market Size by Region (2020-2025)
Figure 40. North America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 43. North America Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 45. U.S. Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Passive Immunizing Drugs Against Rabies Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Passive Immunizing Drugs Against Rabies Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Passive Immunizing Drugs Against Rabies Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Passive Immunizing Drugs Against Rabies Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 53. Europe Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 55. Germany Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Passive Immunizing Drugs Against Rabies Sales Market Share by Region in 2024
Figure 67. Asia Pacific Passive Immunizing Drugs Against Rabies Market Size by Region in 2024
Figure 68. China Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 79. South America Passive Immunizing Drugs Against Rabies Sales Market Share by Country in 2024
Figure 80. South America Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (M USD)
Figure 81. South America Passive Immunizing Drugs Against Rabies Market Size by Country in 2024
Figure 82. Brazil Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Passive Immunizing Drugs Against Rabies Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Passive Immunizing Drugs Against Rabies Market Size by Region in 2024
Figure 92. Saudi Arabia Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Passive Immunizing Drugs Against Rabies Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Passive Immunizing Drugs Against Rabies Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Passive Immunizing Drugs Against Rabies Production Market Share by Region (2020-2025)
Figure 103. North America Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 106. China Passive Immunizing Drugs Against Rabies Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Passive Immunizing Drugs Against Rabies Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Passive Immunizing Drugs Against Rabies Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Passive Immunizing Drugs Against Rabies Market Share Forecast by Type (2026-2035)
Figure 111. Global Passive Immunizing Drugs Against Rabies Sales Forecast by Application (2026-2035)
Figure 112. Global Passive Immunizing Drugs Against Rabies Market Share Forecast by Application (2026-2035)
